Johnson & Johnson

Type: Company
Name: Johnson & Johnson
Nationality: United States
Fact Sheet: Fact Sheet for Johnson & Johnson
First reported 12 hours ago - Updated 18 mins ago - 1 reports

eBay Separates PayPal, J&J to Acquire Alios BioPharma for $1.8 B

12:40 PM New York – eBay to separate its marketplace and PayPal businesses in 2015. Johnson & Johnson plans to acquire privately held Alios BioPharma for $1.8 billion. Walgreen net swung to a loss.Tollbooth Index gained 0.5% or 45.74 to 9,314.30.Earnings ... [Published Ticker - 12 hours ago]
First reported 16 hours ago - Updated 2 hours ago - 20 reports

Firm Advises Alios BioPharma in $1.75B Acquisition by Johnson & Johnson

South San Francisco-based Alios BioPharma, Inc., a biotechnology company developing proprietary therapeutics for viral diseases, has announced a definitive agreement with Johnson & Johnson whereby Alios will be acquired for approximately $1.75 billion ... [Published Latham & Watkins - 2 hours ago]
First reported 16 hours ago - Updated 5 hours ago - 17 reports

Cravath Helps Johnson & Johnson Bag Another Pharma Firm

Drug and pharmaceutical giant Johnson & Johnson has agreed to pay $1.75 billion in cash to acquire Alios BioPharma, a private biotechnology company developing a medicine to combat a serious childhood respiratory infection for which there is no current ... [Published American Lawyer.com - 5 hours ago]
First reported 11 hours ago - Updated 7 hours ago - 1 reports

Apple Smartwatch Production to Begin in 2015, iPhone 6 Hits China Stores Sooner

Rumors are circulating in Apple’s supply chain that the tech giant will begin mass producing its “smartwatch” in January . Additionally, Quanta Computer, an electronics manufacturer in Taiwan, has reportedly been chosen to produce the new Apple devic ... [Published Spend Matters - 11 hours ago]
First reported 16 hours ago - Updated 10 hours ago - 4 reports

Johnson & Johnson to buy private drug developer for $1.75 billion

J&J has been increasing its focus on treatments for infectious diseases, having signed two other deals earlier this year – one for the maintenance treatment of people with HIV and the second to treat influenza.Alios's experimental drug, AL-8176, to treat ... [Published NewsRT.co.uk - 10 hours ago]
First reported 11 hours ago - Updated 10 hours ago - 4 reports

Defective Surgical Product Lawsuits Filed Against Johnson & Johnson

Johnson & Johnson has been accused of knowingly developing and marketing a defective medical device known as Prolene® mesh used in hernia surgery in a series of lawsuits filed in…Click to Continue » ... [Published Fort Mills Times - 10 hours ago]
First reported 13 hours ago - Updated 11 hours ago - 2 reports

Johnson & Johnson Is The Most Attractive Mega-Cap Pharma Stock For Income Investors

By Stock Market Sherpa :Dividend investors have become increasingly drawn to healthcare stocks as a way to generate income in their portfolios and capitalize on an aging population. This article compares four mega- cap pharmaceutical stocks that are based ... [Published BioPortfolio - 11 hours ago]
First reported 18 hours ago - Updated 17 hours ago - 2 reports

The Spooky Truth: What You Need To Know About Contact Lens Hygiene

As Halloween approaches, Johnson & Johnson Vision Care, Inc. Offers Consumers Advice and Resources on Safe Contact Lens Wear and CareJACKSONVILLE, Fla. , Sept. 30, 2014 /PRNewswire/ -- Come fall, many children, teenagers, and even adults begin to think ... [Published Minyanville - 18 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Johnson & Johnson Schedules Conference Call to Discuss 3Q 2014 Results

Johnson & Johnson will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 14, to review third-quarter results. In its release, the Company said that Dominic Caruso, Vice President, Finance and Chief Financial Officer and ... [Published Individual.com - 23 hours ago]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

Research and Markets: Global Antibiotics Market 2014-2018: AstraZeneca, Eli Lilly, GSK, Johnson & Johnson, Novartis, Pfizer & Sanofi Lead the Market

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fqrtz8/global) has announced the addition of the "Global Antibiotics Market 2014-2018" report to their offering. The analysts forecast the Global Antibiotics market ... [Published Business Wire Health News - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

32 years later, the Chicago Tylenol murder mystery still not solved

Early on the morning of Sept. 29, 1982, a tragic, medical mystery began with a sore throat and a runny nose. It was then that Mary Kellerman, a 12-year-old girl from Elk Grove Village, a suburb of Chicago, told her mother and father about her symptoms. ... [Published PBS - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

How Poisoned Tylenol Became a Crisis-Management Teaching Model

The killer’s motives remain unknown, but his — or her, or their — technical savvy is as chilling today as it was 30 years ago. On Sept. 29, 1982, three people died in the Chicago area after taking cyanide-laced Tylenol at the outset of a poisoning ... [Published TIME.com - Sep 29 2014]

Quotes

"In medicine, recognize that some conflicts of interest are inevitable" Ehman said. "We identify them and manage them."
..." She will report to Jeff Harmening, executive VP and chief operating officer for U S retail. "Ann is a world-class marketer who has spent nearly two decades at General Mills as a steward for our company's biggest brands" Mr. Harmening said
"Ann is a world-class marketer who has spent nearly two decades at General Mills as a steward for our company's biggest brands," said Harmening.  "As a dedicated and trusted business leader, Ann has been a strong advocate for deep consumer understanding, and has created and advanced leading strategic philanthropy initiatives, such as Cheerios Spoonfuls of Stories literacy program, the Stirring Up Wishes campaign for the Make a Wish Foundation, and Bake the Change, a Betty Crocker program inspiring people to make a difference in the world through baking."
...if those can show a four-log (99.99%) reduction in HCV virus and have a good safety profile," Yee wrote. "Of course, that is not a layup, as we know development of nukes can be extremely difficult and the bar for continued progression is very high. As a reminder, Vertex (NASDAQ: VRTX ) was partnered on two prior Alios nukes and dropped development of both due to a narrow therapeutic window (one weak efficacy, one had signs of liver toxicity)."

More Content

All (3110) | News (2362) | Reports (1) | Blogs (661) | Audio/Video (2) | Fact Sheets (37) | Press Releases (44)
sort by: Date | Relevance
US prices for homes lose steam [Published Journal-Gazette - 37 mins ago]
Schneider Electric to Name Winners of Software ... [Published Automation World - 2 hours ago]
The Global Awards Launches the Young Globals St... [Published ShootOnline - 2 hours ago]
Docs, hospitals collect $3.5 billion from drug,... [Published AZCentral.com - 2 hours ago]
Firm Advises Alios BioPharma in $1.75B Acquisit... [Published Latham & Watkins - 2 hours ago]
Our First Dive Into the New Open Payments System [Published ProPublica: Articles and Investigations - 3 hours ago]
Post-crisis or pre-crisis? [Published Investment Pensions Europe - 4 hours ago]
General Mills CMO Mark Addicks Is Retiring [Published Advertising Age - 4 hours ago]
Cravath Helps Johnson & Johnson Bag Another Pha... [Published American Lawyer.com - 5 hours ago]
Johnson & Johnson to acquire Alios BioPharma fo... [Published PMLive - 5 hours ago]
GENERAL MILLS : chief marketing officer Mark Ad... [Published 4 Traders - 6 hours ago]
Drug, Medical Device Industry Paid U.S. Doctors... [Published GARP - 6 hours ago]
Ebola Shot Turned Down by WHO Is Best Hope as V... [Published Bloomberg - 6 hours ago]
[Free Report] JNJ Aquires Alios: What This Mean... [Published Chimera Research Group - Proceed With Confidence - 7 hours ago]
Advertising Week – Wednesday: Yannick Bolloré, ... [Published The Drum - 7 hours ago]
J&J's Alios Buyout Bodes Interesting Times For ... [Published Investor's Business Daily - 7 hours ago]
Johnson & Johnson Bets $1.75 Billion On Alios Buy [Published Yahoo! Finance - 7 hours ago]
Finance News Update, what you need to know (AAP) [Published West Australian - 7 hours ago]
Kirchner Using Argentine Debt Issue as Distract... [Published Bloomberg - 7 hours ago]
AOL to deliver more video news to Microsofts MS... [Published Austinnews.net - 8 hours ago]
Johnson & Johnson to buy private drug developer... [Published NewsRT.co.uk - 10 hours ago]
Cyanide, Tylenol and How Free Markets Make You ... [Published HighBeam Research - 10 hours ago]
UPDATE 2-Johnson & Johnson to buy private drug ... [Published Reuters - 10 hours ago]
Defective Surgical Product Lawsuits Filed Again... [Published Fort Mills Times - 10 hours ago]
Defective Surgical Product Lawsuits Filed Again... [Published EON Business - 10 hours ago]
Defective Surgical Product Lawsuits Filed Again... [Published Business Wire Professional Services News - 11 hours ago]
UPDATED: J&J buys Alios for $1.75 billion [Published Pharma Times - 11 hours ago]
Defective Surgical Product Lawsuits Filed Again... [Published Town Hall - 11 hours ago]
Johnson & Johnson Acquires Alios BioPharma for ... [Published PharmTech.com - 11 hours ago]
Apple Smartwatch Production to Begin in 2015, i... [Published Spend Matters - 11 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
[Free Report] JNJ Aquires Alios: What This Mean... [Published Chimera Research Group - Proceed With Confidence - 7 hours ago]
Johnson & Johnson announced today it will acquire privately held Alios BioPharma for $1.75 Billion in cash, gaining rights to the mid-stage treatment for infants with respiratory syncytial virus (RSV),. The post [Free Report] JNJ Aquires Alios: What ...
Defective Surgical Product Lawsuits Filed Again... [Published EON Business - 10 hours ago]
PALM BEACH GARDENS, Fla.--(EON: Enhanced Online News)--Johnson & Johnson has been accused of knowingly developing and marketing a defective medical device known as Prolene® mesh used in hernia surgery in a series of lawsuits filed in New Jersey Superior ...
Defective Surgical Product Lawsuits Filed Again... [Published Business Wire Professional Services News - 11 hours ago]
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Johnson & Johnson has been accused of knowingly developing and marketing a defective medical device known as Prolene® mesh used in hernia surgery in a series of lawsuits filed in New Jersey Superior Court. The ...
What Johnson & Johnson’s Alios Acquisition Mean... [Published BARRONS.com Stocks To Watch Today - 11 hours ago]
RBC Capital Market’s Michael Yee and team look at what Johnson & Johnson’s (JNJ) acquisition of Alios BioPharma means for Gilead Sciences (GILD): Johnson & Johnson announced an agreement to acquire Alios BioPharma for $1.75B in cash. We generally agree ...
Johnson & Johnson to Buy Biotech Company Alios [Published DealBook - 15 hours ago]
The $1.75 billion deal for Alios BioPharma marks the first acquisition in some time for Johnson & Johnson. Alios is working on treatments for viral diseases. ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
The Market Ends the Session Lower [Published Wall Street Journal What's News - Sep 04 2014]
Inflation Rose Last Month [Published Wall Street Journal What's News - Apr 15 2014]
1

Press Releases

sort by: Date | Relevance
The Zacks Analyst Blog Highlights: Gilead Scien... [Published Financial Services - Sep 29 2014]
Pharma Stocks Review - AbbVie, Merck, Johnson a... [Published Financial Services - Sep 25 2014]
New Product Launch, Accelerated Drug Approvals,... [Published Financial Services - Sep 15 2014]
Transvaginal Mesh Lawsuit Latest Update News: J... [Published Financial Services - Sep 09 2014]
The Zacks Analyst Blog Highlights: Intel, Advan... [Published Financial Services - Sep 08 2014]
1 2 3 4 5 6 7 8 9
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.